Shilpa Medicare · NSE: SHILPAMED · BSE: 530549
Q4 FY26 results · Jan–Mar 2026
Shilpa Medicare reported revenue from operations of ₹436.99 crore (up 32.1% from Q4 FY25) and net profit of ₹107.79 crore (up 642.9% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 436.99 | 330.80 | +32.1% | 409.73 | +6.7% |
| Other income | 1.67 | 7.57 | −77.9% | 0.81 | +105.1% |
| Total income | 438.66 | 338.38 | +29.6% | 410.54 | +6.8% |
| Profit before tax | 120.45 | 12.98 | +828.2% | 61.21 | +96.8% |
| Net profit for the period | 107.79 | 14.51 | +642.9% | 44.58 | +141.8% |
| EPS, basic (₹) | 5.51 | 1.48 | not comparable | 2.36 | +133.5% |
| Net margin (%) | 24.7 | 4.4 | 10.9 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 201.11 | 126.15 | +59.4% | 165.70 | +21.4% |
| Other income | 6.89 | 14.08 | −51.1% | 11.29 | −39.0% |
| Total income | 208.00 | 140.24 | +48.3% | 176.99 | +17.5% |
| Profit before tax | 78.02 | (9.43) | Turned profit | 23.79 | +228.0% |
| Net profit for the period | 70.97 | (5.15) | Turned profit | 15.93 | +345.4% |
| EPS, basic (₹) | 3.63 | (0.53) | not comparable | 0.84 | +332.1% |
| Net margin (%) | 35.3 | -4.1 | 9.6 |
Consolidated
- Filed with BSE
- 22 May 2026, 17:44 IST
- Board meeting
- 22 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 22 May 2026, 17:44 IST
- Board meeting
- 22 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE